Geneva, 2 September 2021 – The first shipments of Canada’s pledge of over 40 million doses to COVAX are arriving today, with Nigeria (801,600 doses), Kenya (459,300) and Niger (100,800) the first to receive deliveries of Canadian-donated doses. This comes alongside a pledge of CAD 440 million to the COVAX Advance Market Commitment for procurement of vaccines and CAD 75 million for readiness and delivery by the Government of Canada (including CAD 5 million for operationalization of the COVAX dose sharing mechanism), making Canada one of the largest donors to COVAX. An additional CAD 30 million was reallocated from the sunsetting Pneumococcal Advance Market Commitment in 2020 to help launch the COVAX AMC. The Honourable Karina Gould, Minister of International Development, has served as one of the three co-chairs of the AMC Engagement Group.
Canada has long been a strong supporter of global public health and shown longstanding commitment to multilateralism, responding to the COVID-19 pandemic in a co-operative and collaborative way by tackling inequity. Since its inception, Canada has contributed CAD 1.3 billion to the Access to COVID-19 Tools (ACT) Accelerator, of which COVAX is the vaccine pillar. With this dose donation, Canada takes another step to protect vulnerable populations around the world. In addition, since 2002 Canada has contributed over CAD 1 billion through Gavi and is a founding donor of the Pneumococcal Advance Market Commitment.
“As one of our strongest supporters, Canada has pledged over CAD 500 million to the COVAX Advance Market Commitment and will donate over 40 million vaccine doses,” said Dr Seth Berkley, CEO of Gavi, the Vaccine Alliance. “We are delighted to see Canadian doses reach people who need them the most, and this underlines Canada’s commitment to leave no-one behind and get vaccines in arms. We know that Canada is committed to helping everyone, everywhere recover from the pandemic, and to strengthening health systems.”
These doses donated by Canada are produced by the AstraZeneca manufacturing network. Donating through COVAX helps to increase vaccine coverage, ensures that no dose goes to waste, and helps to bring an end to the acute phase of the pandemic.
Gavi and COVAX partners are working with governments to overcome legal and logistical hurdles to turn pledges totalling over 600 million doses into deliveries, to ensure that doses can reach countries quickly in the weeks and months to come. Over 100 million donated doses have already been delivered.